Literature DB >> 82547

Studies on Epstein-Barr virus-related antigens. III. Purification of the virus-determined nuclear antigen (EBNA) from non-producer Raji cells.

T Matsuo, N Hibi, S Nishi, H Hirai, T Osato.   

Abstract

The purification of Epstein-Barr virus-determined nuclear antigen (EBNA) was attempted on the basis of its biochemical and physicochemical properties and its immunological specificity, assayed by the indirect single radial immunodiffusion test and anti-complement immunofluorescence absorption test. When non-producer Raji cell extract was subjected to 20--60% saturated ammonium sulfate fractionation, followed by DNA-cellulose chromatography and immunoadsorbent chromatography, EBNA was purified more than 3,000 times with a 8% yield. Such purified protein was composed of three polypeptides with molecular weights of 100,000 +/- 5,000, 70,000 +/- 5,000 and 50,000 daltons, respectively, on SDS-polyacrylamide gel electrophoresis. Similar purification was achieved by heating the extract at 70 degrees C for 10 min, instead of ammonium sulfate fractionation, followed by DNA-cellulose chromatography and immunoadsorbent chromatography. This final preparation consisted almost exclusively of 100,000 +/- 5,000 daltons polypeptide, 50,000 polypeptide, and the 70,000 +/- 5,000 polypeptide passing through the adsorbent column. These findings suggest that EBNA is probably a molecular complex of three smaller subunits of heat-stable 100,000 +/- 5,000 and 50,000 daltons and heat-labile 70,000 +/- 5,000 daltons polypeptides, respectively.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 82547     DOI: 10.1002/ijc.2910220618

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Identification and characterization of a cellular protein that cross-reacts with the Epstein-Barr virus nuclear antigen.

Authors:  J Luka; T Kreofsky; G R Pearson; K Hennessy; E Kieff
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

2.  Evidence for two classes of chromatin-associated Epstein-Barr virus-determined nuclear antigen.

Authors:  T C Spelsberg; T B Sculley; G M Pikler; J A Gilbert; G R Pearson
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

3.  Polypeptides of the Epstein-Barr virus membrane antigen complex.

Authors:  D A Thorley-Lawson; C M Edson
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

4.  Identification of Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9-kilobase-pair subfragment of the genome.

Authors:  D K Fischer; M F Robert; D Shedd; W P Summers; J E Robinson; J Wolak; J E Stefano; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

5.  Analysis of the transformation of human lymphocytes by Epstein-Barr virus III. Induction of early events by P3HR-1 strain without subsequent immortalization.

Authors:  K Takada; T Osato
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

6.  Antibodies to the Epstein-Barr virus nuclear antigen and to rheumatoid arthritis nuclear antigen identify the same polypeptide.

Authors:  P B Billings; S O Hoch; P J White; D A Carson; J H Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

7.  Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen.

Authors:  J Dillner; L Sternås; B Kallin; H Alexander; B Ehlin-Henriksson; H Jörnvall; G Klein; R Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.